Jane Street’s Haemonetics HAE Stock Holding History

Jane Street’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360K	Buy	4,800 +100	+2%	+$6.42K	﹤0.01%	8798
2026 Q1	$265K	Buy	+4,700	New	+$306K	﹤0.01%	9501
2025 Q4	–	Sell	-21,800	Closed	-$1.06M	–	11635
2025 Q3	$1.06M	Buy	21,800 +19,000	+679%	+$1.18M	﹤0.01%	6184
2025 Q2	$209K	Buy	+2,800	New	+$185K	﹤0.01%	8469
2025 Q1	–	Sell	-15,000	Closed	-$1.17M	–	9876
2024 Q4	$1.17M	Buy	+15,000	New	+$1.2M	﹤0.01%	5073
2023 Q2	–	Sell	-6,900	Closed	-$571K	–	9031
2023 Q1	$571K	Buy	+6,900	New	+$559K	﹤0.01%	6104
2022 Q1	–	Sell	-5,100	Closed	-$271K	–	10578
2021 Q4	$271K	Sell	5,100 -3,700	-42%	-$225K	﹤0.01%	8360
2021 Q3	$621K	Buy	8,800 +1,000	+13%	+$63.1K	﹤0.01%	6863
2021 Q2	$520K	Buy	+7,800	New	+$552K	﹤0.01%	7161
2020 Q3	–	Sell	-14,500	Closed	-$1.3M	–	7438
2020 Q2	$1.3M	Buy	+14,500	New	+$1.46M	﹤0.01%	3688

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's HAE Position: Q2 2026 in Review

Jane Street sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 152,958 shares — an estimated $9.83M sold.

Jane Street first reported a position in HAE in Q4 2013 and held it in 30 quarters. The position peaked at $42.2M in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Jane Street reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
Jane Street sold 152,958 Haemonetics shares in Q2 2026, an estimated $9.83M.
Jane Street first reported a position in Haemonetics in Q4 2013 and held it in 30 quarters.
Jane Street's Haemonetics position peaked at $42.2M in Q4 2025.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.